Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.
Creative Medical Technology Holdings (CELZ) Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine using AlloStem streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on.
On a fine Saturday morning, swimmers took the plunge into the Atlantic Ocean to raise money for Canadian Mental Health Association of NL’s annual Tickle Swim fundraiser
It's long, it's cold and it's tiring, but for 11 years now swimmers have pushed themselves to cross the Tickle from Portugal Cove-St. Philip's to Bell Island in the name of mental health.